NeuroOne

Curated by Signal

Developer of AI-enabled diagnostic and treatment devices for neurological diseases

Overview

NeuroOne is developing AI-enabled diagnostic and treatment devices for neurological diseases. The minimally invasive diagnostic and therapeutic devices are developed using the company's thin-film electrode technology that enables minimally invasive placement of the device to monitor and record the neural activity. It is used in Intracranial (iEEG) recording, stimulation for Electrocorticography (ECoG), Stereoelectroencephalography (sEEG), ablation, and electrodes for chronic stimulation.

Key facts

Founded: 2017
Headquarters: Eden Prairie, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Molecular Targeting Technology
Digital image diagnosis tool for providers
Life Sciences TechnologyWest, United States
Cervel
Non-invasive neuromodulation through transcranial magnetic stimulation to treat treatment resistant depression
Life Sciences TechnologyRedwood City, United States
Pendar Technologies
Provider of a spectroscopic analytical instrument system
Life Sciences TechnologyCambridge, United States

About NeuroOne

What does NeuroOne do?

NeuroOne is developing AI-enabled diagnostic and treatment devices for neurological diseases.

Where is NeuroOne headquartered?

NeuroOne is headquartered in Eden Prairie, United States.

When was NeuroOne founded?

NeuroOne was founded in 2017.

Which sector is NeuroOne in?

NeuroOne operates in Life Sciences Technology.

Who are NeuroOne's competitors?

Companies similar to NeuroOne include Molecular Targeting Technology, Cervel, and Pendar Technologies.